Breaking news

Gold’s Gleam: Caution Amid The Rally

Gold prices are surging, with the SPDR Gold Shares (GLD) fund up about 11% in 2025 and returns climbing roughly 42% over the past year. Gold futures, too, are on the rise—up around 10% year-to-date and 36% higher than last year. By contrast, the S&P 500 has barely moved in 2025, gaining only 1.5%, and has risen 17% over the past year.

Yet, as the allure of the precious metal intensifies, seasoned investors are urging restraint. Certified financial planner Lee Baker of Claris Financial Advisors recalls, “I didn’t get any calls from clients about gold a year ago. Now, I get them regularly.” He cites Warren Buffett’s timeless advice: “Be cautious when others are greedy, and be greedy when others are fearful.” Baker warns that while the current fervor is tempting, the typical investor should limit gold allocation to no more than 3% of a diversified portfolio—lest they fall into the classic trap of buying high and selling low.

Why are gold prices on the rise? The answer lies in its enduring reputation as a safe haven during turbulent times. Investors flock to gold amid uncertainty, with recent US sanctions against Russia acting as a turbocharger for returns. These sanctions have spurred central banks, particularly in China, to boost their gold purchases instead of U.S. Treasury bonds, aiming to safeguard their reserves from potential geopolitical strife. Moreover, many see gold as a hedge against inflation, even though the data supporting that view remains mixed.

Samir Samana, senior global market strategist at Wells Fargo Investment Institute, notes, “In times of real crisis, bonds have shone brighter than gold.” His perspective underscores that while gold may shine during periods of high uncertainty, its rally might be unsustainable without a prolonged crisis.

For investors, the takeaway is clear: while gold’s current surge offers attractive returns, caution is paramount. As the market faces potential headwinds, following Buffett’s contrarian wisdom may help avoid the pitfalls of an overheated market. In the world of investing, where timing is everything, it’s not just about chasing returns—it’s about staying disciplined when the herd runs wild.

Medochemie And Theramir Announce Strategic Investment Agreement To Advance Biotech Manufacturing In Cyprus

Pharmaceutical manufacturer Medochemie and biotechnology company Theramir, both Cyprus-based, have announced a strategic investment agreement and collaboration aimed at developing next-generation biological therapies and expanding manufacturing capabilities in Cyprus.

The agreement, announced on 2 September 2026, brings together Medochemie’s experience in pharmaceutical manufacturing and Theramir’s biotechnology research. The companies said the collaboration would support advanced pharmaceutical manufacturing in Cyprus and south-eastern Europe.

What The Partnership Covers

Medochemie’s contribution will include its expertise in manufacturing sterile therapeutic products and its access to international markets.

Theramir develops technologies based on extracellular vesicles and microRNAs. Its work includes using stem-cell-derived extracellular vesicles to deliver microRNAs, small, non-coding RNA molecules that regulate genes and biological pathways associated with cancer growth and metastasis.

Under the agreement, the companies will jointly support the development of “Good Manufacturing Practice” capabilities for next-generation biological therapies. The partnership is also intended to help move these therapies towards clinical development.

A Wider Role For Cyprus

The collaboration will also support Theramir’s wider research programme. According to the companies, it is intended to strengthen Cyprus’s biotechnology infrastructure and expand local capacity in next-generation biomanufacturing.

They present the agreement as a step towards giving Cyprus a larger role in biotechnology and advanced pharmaceutical manufacturing for south-eastern Europe and international markets.

eCredo
Uol
Aretilaw firm
The Future Forbes Realty Global Properties

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter